NOW APPROVED AND AVAILABLE for adults and children with hemophilia A with factor VIII inhibitors
We extend our appreciation to the individuals, families, and healthcare providers who participated in the clinical trials that led to the approval of HEMLIBRA®. We thank you and celebrate with the community that made it a reality.
Sign up for Connects Patient Resource Center and register for a special webcast to learn more about HEMLIBRA.
What Is HEMLIBRA?
A new treatment option for hemophilia A with factor VIII inhibitors
How HEMLIBRA Is Made
Genentech’s manufacturing process and standards
Services that may help you access HEMLIBRA
Connects Patient Resource Center
HEMLIBRA support and resources